TCM
RMD icon

Telos Capital Management’s ResMed RMD Stock Holding History

Telos Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.98M Buy
35,801
+2
+0% +$415 0.61% 58
2026
Q1 		$8.04M Buy
35,799
+2,730
+8% +$680K 0.77% 47
2025
Q4 		$7.97M Buy
33,069
+1,687
+5% +$431K 0.74% 46
2025
Q3 		$8.59M Buy
31,382
+661
+2% +$181K 0.82% 41
2025
Q2 		$7.93M Buy
30,721
+216
+0.7% +$51.5K 0.81% 43
2025
Q1 		$6.83M Buy
30,505
+206
+0.7% +$48.1K 0.74% 48
2024
Q4 		$6.93M Sell
30,299
-78
-0.3% -$18.8K 0.74% 50
2024
Q3 		$7.42M Buy
30,377
+479
+2% +$107K 0.78% 44
2024
Q2 		$5.72M Buy
29,898
+1,016
+4% +$206K 0.63% 55
2024
Q1 		$5.72M Buy
28,882
+1,366
+5% +$250K 0.64% 56
2023
Q4 		$4.73M Buy
27,516
+3,204
+13% +$492K 0.58% 70
2023
Q3 		$3.59M Buy
24,312
+1,346
+6% +$243K 0.5% 69
2023
Q2 		$5.02M Buy
22,966
+635
+3% +$142K 0.67% 56
2023
Q1 		$4.89M Buy
22,331
+1,016
+5% +$220K 0.68% 56
2022
Q4 		$4.44M Buy
21,315
+1,015
+5% +$223K 0.65% 61
2022
Q3 		$4.43M Buy
20,300
+515
+3% +$117K 0.73% 50
2022
Q2 		$4.15M Buy
19,785
+1,148
+6% +$244K 0.63% 60
2022
Q1 		$4.52M Buy
18,637
+801
+4% +$194K 0.59% 62
2021
Q4 		$4.65M Buy
17,836
+130
+0.7% +$33.7K 0.58% 61
2021
Q3 		$4.67M Sell
17,706
-4,391
-20% -$1.2M 0.64% 56
2021
Q2 		$5.45M Buy
22,097
+1,005
+5% +$211K 0.72% 49
2021
Q1 		$4.09M Buy
21,092
+1,520
+8% +$305K 0.59% 61
2020
Q4 		$4.16M Buy
19,572
+201
+1% +$40.1K 0.63% 58
2020
Q3 		$3.32M Buy
19,371
+831
+4% +$153K 0.58% 63
2020
Q2 		$3.56M Sell
18,540
-424
-2% -$69.4K 0.69% 53
2020
Q1 		$2.79M Sell
18,964
-6,618
-26% -$1.05M 0.69% 50
2019
Q4 		$3.96M Sell
25,582
-383
-1% -$55.2K 0.9% 44
2019
Q3 		$3.51M Sell
25,965
-1,003
-4% -$131K 0.96% 39
2019
Q2 		$3.29M Buy
26,968
+947
+4% +$105K 0.96% 40
2019
Q1 		$2.71M Buy
26,021
+1,862
+8% +$192K 0.84% 46
2018
Q4 		$2.75M Buy
24,159
+612
+3% +$65.6K 1.02% 37
2018
Q3 		$2.72M Sell
23,547
-5,592
-19% -$613K 0.87% 44
2018
Q2 		$3.02M Sell
29,139
-202
-0.7% -$20.4K 1.04% 32
2018
Q1 		$2.89M Sell
29,341
-343
-1% -$32.4K 1.03% 36
2017
Q4 		$2.51M Sell
29,684
-678
-2% -$56K 0.89% 46
2017
Q3 		$2.34M Sell
30,362
-223
-0.7% -$17.1K 0.9% 49
2017
Q2 		$2.38M Sell
30,585
-3,493
-10% -$250K 0.95% 43
2017
Q1 		$2.45M Sell
34,078
-1,038
-3% -$71.7K 1.02% 36
2016
Q4 		$2.18M Buy
35,116
+1,358
+4% +$83.2K 0.97% 39
2016
Q3 		$2.19M Sell
33,758
-414
-1% -$27.6K 1.02% 36
2016
Q2 		$2.16M Buy
34,172
+1,773
+5% +$105K 1.06% 35
2016
Q1 		$1.87M Buy
32,399
+1,788
+6% +$101K 0.98% 38
2015
Q4 		$1.64M Sell
30,611
-4,254
-12% -$240K 0.89% 42
2015
Q3 		$1.78M Buy
34,865
+1,545
+5% +$83.2K 1.09% 35
2015
Q2 		$1.88M Buy
+33,320
New +$2.1M 1.04% 35

Other funds holding RMD

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
CISOA
Capital Investment Services of America Milwaukee, Wisconsin $1.02B AUM 3.04% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Telos Capital Management's RMD Position: Q2 2026 in Review

Telos Capital Management increased its ResMed (RMD) stake by 0.01% in Q2 2026, buying an estimated $415 and bringing the position to 35,801 shares worth $6.98M. The position accounts for 0.61% of the portfolio, ranked #58.

Telos Capital Management first reported a position in RMD in Q2 2015 and has held it in 45 quarters since. The position peaked at $8.59M in Q3 2025. 200 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Telos Capital Management held 35,801 shares of ResMed worth $6.98M as of Q2 2026.
  • Telos Capital Management bought 2 ResMed shares in Q2 2026, an estimated $415.
  • ResMed made up 0.61% of Telos Capital Management's portfolio in Q2 2026, its #58 holding.
  • Telos Capital Management first reported a position in ResMed in Q2 2015 and has held it in 45 quarters since.
  • Telos Capital Management's ResMed position peaked at $8.59M in Q3 2025.
  • 200 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Telos Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.